These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 474380)
21. Electrophysiologic effects of disopyramide in children. Kashani IA; Shakibi JG; Siassi B Jpn Heart J; 1980 Jul; 21(4):491-6. PubMed ID: 7420732 [TBL] [Abstract][Full Text] [Related]
22. Effects of the new class I antiarrhythmic agent Ro 22-9194, (2R)-2-amino-N-(2,6-dimethylphenyl)-N-[3-(3-pyridyl)propyl]propionamide D-tartrate, on ischemia- and reperfusion-induced arrhythmias in dogs: involvement of thromboxane A2 synthase inhibitory activity. Murakami M; Kinukawa M; Kanazawa T; Maruyama K; Miyagi M; Miyata H; Ujiie A J Pharmacol Exp Ther; 1996 Nov; 279(2):877-83. PubMed ID: 8930195 [TBL] [Abstract][Full Text] [Related]
23. Disopyramide: a review of its pharmacological properties and therapeutic use in treating cardiac arrhythmias. Heel RC; Brogden RN; Speight TM; Avery GS Drugs; 1978 May; 15(5):331-68. PubMed ID: 350555 [TBL] [Abstract][Full Text] [Related]
24. Clinical pharmacology of the antiarrhythmic agent disopyramide phosphate (Norpace). Befeler B; Lazzara R Heart Lung; 1980; 9(3):475-82. PubMed ID: 6901520 [No Abstract] [Full Text] [Related]
25. [Clinical and hemodynamic effects of disopyramide phosphate administered i.v. in cardiopathic subjects (author's transl)]. Chiariello M; Santinelli V; Ferro G; Tari MG; Stanislao M; Condorelli M G Ital Cardiol; 1979; 9(9):975-83. PubMed ID: 520746 [TBL] [Abstract][Full Text] [Related]
26. Effect of drugs on conduction delay and incidence of ventricular arrhythmias induced by acute coronary occlusion in dogs. Elharrar V; Gaum WE; Zipes DP Am J Cardiol; 1977 Apr; 39(4):544-9. PubMed ID: 848439 [TBL] [Abstract][Full Text] [Related]
27. Relationship of alternans of monophasic action potential and conduction delay inside the ischemic border zone to serious ventricular arrhythmia during acute myocardial ischemia in dogs. Abe S; Nagamoto Y; Fukuchi Y; Hayakawa T; Kuroiwa A Am Heart J; 1989 Jun; 117(6):1223-33. PubMed ID: 2729052 [TBL] [Abstract][Full Text] [Related]
28. Electrophysiologic effects of disopyramide phosphate in patients with Wolff-Parkinson-White syndrome. Kerr CR; Prystowsky EN; Smith WM; Cook L; Gallagher JJ Circulation; 1982 May; 65(5):869-78. PubMed ID: 6804107 [TBL] [Abstract][Full Text] [Related]
29. Antiarrhythmic effects of optical isomers of disopyramide on canine ventricular arrhythmias. Nakamura M; Xue Y; Eto K; Hashimoto K J Cardiovasc Pharmacol; 1996 Mar; 27(3):368-75. PubMed ID: 8907798 [TBL] [Abstract][Full Text] [Related]
30. Effects of procainamide on the dispersion of recovery of excitability during coronary occlusion. Levites R; Haft JI; Calderon J; Venkatachalapathy Circulation; 1976 Jun; 53(6):982-4. PubMed ID: 1269135 [TBL] [Abstract][Full Text] [Related]
34. Effects of aprindine and disopyramide on reperfusion-induced arrhythmias and cardiac function in isolated rat hearts. Iwasaki S; Araki H; Yamakawa T; Nishi K; Miyauchi Y Arch Int Pharmacodyn Ther; 1989; 300():174-85. PubMed ID: 2619422 [TBL] [Abstract][Full Text] [Related]
35. [Disopyramide phosphate: the electrophysiological mechanisms of its anti-arrhythmia action and its use in clinical practice]. Grosu AA Kardiologiia; 1985 May; 25(5):114-8. PubMed ID: 3894756 [No Abstract] [Full Text] [Related]
36. [Electrophysiological effects of the antiarrhythmia agents disopyramide and propafenone on human heart conduction system]. Seipel L; Breithardt G; Both A Z Kardiol; 1975 Aug; 64(8):731-40. PubMed ID: 1163095 [TBL] [Abstract][Full Text] [Related]
37. Electrophysiologic effects of disopyramide in patients with atrioventricular nodal dysfunction. Wilkinson PR; Desai J; Hollister J; Gonzalez R; Abbott JA; Scheinman MM Circulation; 1982 Dec; 66(6):1211-6. PubMed ID: 7139899 [TBL] [Abstract][Full Text] [Related]